Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Recurrence 1Neoplasms by Histologic Type 1Neoplasms 1Lymphoproliferative Disorders 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lymphatic Diseases 1Immunoproliferative Disorders 1Immune System Diseases 1AIDS-Related Complex 1

Interventions

dacetuzumab 5blinatumomab 4Bortezomib 4Lenalidomide 3Dexamethasone 3Rituximab 2tetulomab tetraxetan lu-177 1ponatinib 1pembrolizumab 1pegaspargase 1isatuximab 1ibrutinib 1ficlatuzumab 1durvalumab 1asparaginase erwinia chrysanthemi recombinant 1acalabrutinib 1Vorinostat 1Methotrexate 1Lutetium 1KW-2478 1Ifosfamide 1Hsp90 inhibitor KU757 1Gemcitabine 1Erlotinib Hydrochloride 1Daunorubicin 1Cyclophosphamide 1Calcium Dobesilate 1Brentuximab Vedotin 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Immunoproliferative Disorders × Lutetium × Clear all
NCT02658968 2024-01-16

Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)

Nordic Nanovector

Phase 1 Completed
18 enrolled 16 charts
Lymphoid

AIDS-Related Complex, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡